ArticleNeuroradiology2026
Differentiating pituitary metastases from pituitary neuroendocrine tumors in patients with a history of malignancy: clinical and magnetic resonance imaging features and quantitative morphometric analysis.
Article in Neuroradiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare the clinical and MRI findings of pituitary metastases (PMs) and pituitary neuroendocrine tumors (PitNETs) in patients with a history of malignancy and to assess quantitative morphologic parameters in dumbbell-shaped lesions.
methodsClinical and MRI data from 13 patients with PMs and 31 patients with PitNETs were retrospectively reviewed. For 27 dumbbell-shaped lesions, quantitative linear measurements were performed, and the R value was defined as the ratio of the neck diameter to the combined suprasellar and intrasellar widths. Receiver operating characteristic analysis assessed diagnostic performance.
resultsPatients with PMs had a shorter symptom-to-detection interval (P = 0.003) and more commonly presented with headache (P = 0.004). Compared with the PitNET group, the PM group showed a higher contrast-enhanced T1-weighted signal intensity ratio (P = 0.035), more frequent pituitary stalk involvement (P = 0.024), less frequent preservation of the posterior pituitary bright spot (P < 0.001), and less frequent sellar enlargement (P = 0.010). In the subgroup with dumbbell-shaped lesions, the PM group had a smaller coronal suprasellar width (P = 0.004), smaller coronal and sagittal neck diameters, and lower coronal and sagittal R values (all P < 0.001). Coronal neck diameter and coronal R value yielded AUCs of 0.986 and 0.971, respectively.
conclusionIn patients with a history of malignancy and a newly detected sellar lesion, a shorter symptom-to-detection interval, headache, pituitary stalk involvement, loss of the posterior pituitary bright spot, marked enhancement, and limited sellar enlargement may suggest PM. In dumbbell-shaped lesions, a smaller neck diameter and lower R value may provide supplementary quantitative information for differentiating PMs from PitNETs.
Indexed as
Identifiers
42820962What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.